IP Library Granted Patent US 9,950,059
Granted Patent B2
US 9,950,059 · App. 15/120,237 · Granted Apr 24, 2018

Immunogenic composition

Inventors: Qingzhong Yu (Athens, GA); Stephen J. Spatz (Athens, GA); Laszlo Zsak (Athens, GA)
Assignee: The United States of America, as represented by the Secretary of Agriculture.
A61K39/17A61K39/12A61K39/245C12N7/00C12N15/86A61K2039/525A61K2039/552C12N2710/16034C12N2760/18034C12N2760/18043C12N2760/18121C12N2760/18134C12N2760/18143
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,950,059
App. No.
15/120,237
Granted
Apr 24, 2018
Kind
B2
Abstract

Recombinant chimeric viruses based on NDV LaSota strain and containing either ILTV gB or gD are produced. Administration of the chimeric viruses to chickens induces an immune response in the animal against both NDV and ILTV. Immunogenic compositions, plasmids, kits and methods are described.

Claims (13)

1. A chimeric virus comprising a Newcastle disease virus (NDV) LaSota strain and a heterologous antigen from infectious laryngotracheitis virus (ILTV), wherein said heterologous antigen is gB and wherein said chimeric virus has a cDNA sequence of SEQ ID NO: 14.

2. The chimeric virus of claim 1 , wherein said chimeric virus contains a negative-strand RNA having the RNA sequence of SEQ ID NO: 15.

3. A chimeric virus comprising a Newcastle disease virus (NDV) LaSota strain and a heterologous antigen from infectious laryngotracheitis virus (ILTV), wherein said heterologous antigen is gD and wherein said chimeric virus has a cDNA sequence of SEQ ID NO: 17.

4. The chimeric virus of claim 3 , wherein said chimeric virus contains a negative-strand RNA having the RNA sequence of SEQ ID NO: 18.

5. An immunogenic composition comprising the chimeric virus of claim 1 , one or more diluents, optionally an adjuvant, and optionally a carrier.

6. A method of generating an immune response to NDV and ILTV in an avian animal comprising administering an immunogenic effective amount of the immunogenic composition of claim 5 to said avian animal.

7. A method of preventing ILTV disease and NDV disease in an avian animal comprising administering an immunogenic effective amount of the immunogenic composition of claim 5 to said avian animal in need thereof.

8. A method of reducing shedding of ILTV and NDV by an avian animal capable of being infected with ILTV and/or NDV comprising administering an immunogenic effective amount of the immunogenic composition of claim 5 to said avian animal.

9. A novel, purified expression vector comprising a polynucleotide sequence selected from the group consisting of SEQ ID NO: 13, and SEQ ID NO: 16.

10. An immunogenic composition comprising the chimeric virus of claim 3 , one or more diluents, optionally an adjuvant, and optionally a carrier.

11. A method of generating an immune response to NDV and ILTV in an avian animal comprising administering an immunogenic effective amount of the immunogenic composition of claim 10 to said avian animal.

12. A method of preventing ILTV disease and NDV disease in an avian animal comprising administering an immunogenic effective amount of the immunogenic composition of claim 10 to said avian animal in need thereof.

13. A method of reducing shedding of ILTV and NDV by an avian animal capable of being infected with ILTV and/or NDV comprising administering an immunogenic effective amount of the immunogenic composition of claim 10 to said avian animal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2018
From: YU, QINGZHONG; SPATZ, STEPHEN J.; ZSAK, LASZLO
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
Reel/Frame 044598/0197 →
Continuity (2)
Provisional Application 61944143 · Feb 25, 2014
Related Publication 20170072046A1 · Mar 16, 2017